Tags

Type your tag names separated by a space and hit enter

Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool.
Headache. 2008 Nov-Dec; 48(10):1419-25.H

Abstract

OBJECTIVE

To develop and validate a brief questionnaire to screen for menstrual migraine (MM), and to estimate MM prevalence in an obstetrics and gynecology (OB/GYN) setting in a pilot study.

METHODS

Patients with unknown MM status from a headache clinic completed a 9-item questionnaire. The attributes of each question were compared with a validated headache calendar to develop a 3-item MM questionnaire. The headache calendar and questionnaire were then administered to nonpregnant/nonmenopausal OB/GYN patients. A diagnosis was assigned by a blinded specialist using the headache calendar, and MM prevalence was determined.

RESULTS

The analysis yielded 3 relevant questions administered to 250 women for our tool, called the Menstrual Migraine Assessment Tool (MMAT): (1) "Do you have headaches that are related to your period (ie, occur between 2 days before the onset of your period, until the third day of your period) most months?" (2) "When my headaches are related to my period, they eventually become severe"; (3) "When my headaches are related to my period, light bothers me more than when I don't have a headache." If question 1 was positive, questions 2 and 3 were answered. Among women responding positively to question 1 and > or =1 other question, the sensitivity and specificity were 0.94 and 0.74, respectively. Of 610 randomly chosen OB/GYN patients, 12.1% had pure MM (ie, migraine exclusively between days +2 and -3 of menses), 10.1% had menstrually related migraine (ie, MM and attacks at other times), and 14.1% had migraine without relation to their menses.

CONCLUSION

The MM screener MMAT exhibits sufficient sensitivity and specificity to assess this frequently disabling condition presenting at the OB/GYN office.

Authors+Show Affiliations

Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Validation Study

Language

eng

PubMed ID

19076645

Citation

Tepper, Stewart J., et al. "Development of a Simple Menstrual Migraine Screening Tool for Obstetric and Gynecology Clinics: the Menstrual Migraine Assessment Tool." Headache, vol. 48, no. 10, 2008, pp. 1419-25.
Tepper SJ, Zatochill M, Szeto M, et al. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool. Headache. 2008;48(10):1419-25.
Tepper, S. J., Zatochill, M., Szeto, M., Sheftell, F., Tepper, D. E., & Bigal, M. (2008). Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool. Headache, 48(10), 1419-25. https://doi.org/10.1111/j.1526-4610.2008.01304.x
Tepper SJ, et al. Development of a Simple Menstrual Migraine Screening Tool for Obstetric and Gynecology Clinics: the Menstrual Migraine Assessment Tool. Headache. 2008 Nov-Dec;48(10):1419-25. PubMed PMID: 19076645.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool. AU - Tepper,Stewart J, AU - Zatochill,Mary, AU - Szeto,Marjorie, AU - Sheftell,Fred, AU - Tepper,Deborah E, AU - Bigal,Marcelo, PY - 2008/12/17/entrez PY - 2008/12/17/pubmed PY - 2009/2/28/medline SP - 1419 EP - 25 JF - Headache JO - Headache VL - 48 IS - 10 N2 - OBJECTIVE: To develop and validate a brief questionnaire to screen for menstrual migraine (MM), and to estimate MM prevalence in an obstetrics and gynecology (OB/GYN) setting in a pilot study. METHODS: Patients with unknown MM status from a headache clinic completed a 9-item questionnaire. The attributes of each question were compared with a validated headache calendar to develop a 3-item MM questionnaire. The headache calendar and questionnaire were then administered to nonpregnant/nonmenopausal OB/GYN patients. A diagnosis was assigned by a blinded specialist using the headache calendar, and MM prevalence was determined. RESULTS: The analysis yielded 3 relevant questions administered to 250 women for our tool, called the Menstrual Migraine Assessment Tool (MMAT): (1) "Do you have headaches that are related to your period (ie, occur between 2 days before the onset of your period, until the third day of your period) most months?" (2) "When my headaches are related to my period, they eventually become severe"; (3) "When my headaches are related to my period, light bothers me more than when I don't have a headache." If question 1 was positive, questions 2 and 3 were answered. Among women responding positively to question 1 and > or =1 other question, the sensitivity and specificity were 0.94 and 0.74, respectively. Of 610 randomly chosen OB/GYN patients, 12.1% had pure MM (ie, migraine exclusively between days +2 and -3 of menses), 10.1% had menstrually related migraine (ie, MM and attacks at other times), and 14.1% had migraine without relation to their menses. CONCLUSION: The MM screener MMAT exhibits sufficient sensitivity and specificity to assess this frequently disabling condition presenting at the OB/GYN office. SN - 1526-4610 UR - https://www.unboundmedicine.com/medline/citation/19076645/Development_of_a_simple_menstrual_migraine_screening_tool_for_obstetric_and_gynecology_clinics:_the_menstrual_migraine_assessment_tool_ L2 - https://doi.org/10.1111/j.1526-4610.2008.01304.x DB - PRIME DP - Unbound Medicine ER -